✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹5,256 Cr.
P/E
22.73
About
Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bangalore, India. The Company has two business verticals, viz., Regulated Markets and Emerging … Read more
Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headqu… Read more
Low
567
52W Range
High
1675
  • Strides Pharma Scien
  • Unichem Lab
  • Gufic Biosciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
50 %
(as of Mar 19)
Acarbose - Market Share
21 %
(as of Mar 19)
Acetazolamide - Market Share
11 %
(as of Mar 19)
Amlodipine - Market Share
18 %
(as of Mar 19)
Benzonatate - Market Share
52 %
(as of Mar 19)
Buspirone - Market Share
36 %
(as of Mar 19)
Calcitriol SGC - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Operating Profit Break-Up

Asset Break-Up - Segment Wise

Asset Break-Up

Operational Metrics

    Select a Metric
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Pediacare
    Suppliers
    • Laurus Labs Ltd.
    • IOL Chemicals And Pharmaceuticals Ltd.
    • HLE Glascoat Ltd.
    FAQs on Strides Pharma Science Ltd. Business

    Strides Pharma Science Limited is a global pharmaceutical company established in 1990, with headquarters in Bangalore, India. It operates in Regulated Markets and Emerging Markets, with a strong R&D facility and presence in 100 countries.

    Strides Pharma Scien major competitors are Unichem Lab, Gufic Biosciences, Sequent Scientific, Guj. Themis Biosyn, FDC, Orchid Pharma, Indoco Remedies.
    Market Cap of Strides Pharma Scien is ₹5,628 Crs.
    While the median market cap of its peers are ₹4,549 Crs.

    Strides Pharma Scien seems to be less financially stable compared to its competitors.
    Altman Z score of Strides Pharma Scien is 2.51 and is ranked 8 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material